PANews reported on October 8th that according to Globenewswire, Nasdaq-listed Predictive Oncology announced that it has completed a $343.5 million PIPE financing. The company will use the funds to purchase ATH tokens on the open market to support its ATH token treasury strategy. (Note: ATH is the native utility token of the Aethir ecosystem)
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.